Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90036043 | 9003604 | 3 | F | 20160707 | 20130108 | 20160908 | PER | US-ASTRAZENECA-2011SE36153 | ASTRAZENECA | 80.00 | YR | F | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90036043 | 9003604 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 21153 | 40 | MG | CAPSULE | QD | ||||||
| 90036043 | 9003604 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 21153 | 1 | DF | CAPSULE | QD | ||||||
| 90036043 | 9003604 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 21153 | 2 | DF | CAPSULE | QD | ||||||
| 90036043 | 9003604 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 90036043 | 9003604 | Arthritis | |
| 90036043 | 9003604 | Arthropathy | |
| 90036043 | 9003604 | Fatigue | |
| 90036043 | 9003604 | Intentional product misuse | |
| 90036043 | 9003604 | Plantar fasciitis | |
| 90036043 | 9003604 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |